• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H2受体阻滞剂应用前后消化性溃疡疾病的外科治疗

Surgical treatment of peptic ulcer disease before and after introduction of H2 blockers.

作者信息

Scheeres D E, DeKryger L L, Dean R E

出版信息

Am Surg. 1987 Jul;53(7):392-5.

PMID:2886084
Abstract

This retrospective study was undertaken to determine if the advent of H2 blockers has altered the surgical treatment and outcome of patients with peptic ulcer disease (PUD). The records of patients having surgery for PUD at Butterworth Hospital, Grand Rapids, Michigan, from 1971-73 (Group 1) and 1981-83 (Group 2) were reviewed. Data recorded included patient and disease characteristics, surgical procedures, morbidity, and mortality. There was a significant difference in mean age: 54 years in Group 1 and 60 years in Group 2. Group 2 had a higher incidence of concomitant medical illnesses. Indications for operation were predominantly of an emergent nature in Group 2, with a marked decline in elective surgeries from 75 per cent to 55 per cent. There was a 15 per cent incidence of nonsurgical complications in Group 2, as opposed to 9 per cent in Group 1. This study demonstrates that the use of H2 blockers and changes in patient characteristics have altered the surgical treatment and outcome of patients with PUD.

摘要

本回顾性研究旨在确定H2阻滞剂的出现是否改变了消化性溃疡疾病(PUD)患者的手术治疗方式及预后。对1971年至1973年期间(第1组)以及1981年至1983年期间(第2组)在密歇根州大急流城巴特沃思医院接受PUD手术治疗的患者记录进行了回顾。记录的数据包括患者及疾病特征、手术方式、发病率和死亡率。两组患者的平均年龄存在显著差异:第1组为54岁,第2组为60岁。第2组合并内科疾病的发生率更高。第2组的手术指征主要为急症性质,择期手术从75%显著下降至55%。第2组非手术并发症的发生率为15%,而第1组为9%。本研究表明,H2阻滞剂的使用以及患者特征的变化改变了PUD患者的手术治疗方式及预后。

相似文献

1
Surgical treatment of peptic ulcer disease before and after introduction of H2 blockers.H2受体阻滞剂应用前后消化性溃疡疾病的外科治疗
Am Surg. 1987 Jul;53(7):392-5.
2
[Role of surgery in the therapy of peptic ulcer after arrival of H2-blocking drugs].[H2 受体阻滞剂出现后手术在消化性溃疡治疗中的作用]
G Chir. 1990 Sep;11(9):466-70.
3
Surgery for peptic ulcer disease in children in the post-histamine2-blocker era.组胺2受体阻滞剂时代儿童消化性溃疡疾病的外科治疗
J Pediatr Surg. 2005 May;40(5):850-4. doi: 10.1016/j.jpedsurg.2005.01.056.
4
[Changes in ulcer surgery following introduction of H2-blockers].[引入H2受体阻滞剂后溃疡手术的变化]
Nord Med. 1991;106(6-7):198-201.
5
Factors affecting mortality in patients operated upon for complications of peptic ulcer disease.影响因消化性溃疡疾病并发症接受手术患者死亡率的因素。
Am Surg. 1989 Jan;55(1):7-11.
6
Abdominal and dyspeptic symptoms in patients with peptic ulcer treated medically or surgically.接受内科或外科治疗的消化性溃疡患者的腹部症状和消化不良症状。
Br J Surg. 1998 Jun;85(6):845-9. doi: 10.1046/j.1365-2168.1998.00711.x.
7
[Ulcer surgery during 1976-1978 and 1986-1988. Significance of H2 blockaders in surgical training].[1976 - 1978年及1986 - 1988年期间的溃疡手术。H2受体阻滞剂在外科培训中的意义]
Ugeskr Laeger. 1993 Nov 22;155(47):3828-32.
8
[Surgical therapy of the peptic ulcer in a hospital specializing in gastroenterology. Effects of therapy with h2 antagonists].[一家胃肠病专科医院的消化性溃疡手术治疗。H2拮抗剂治疗的效果]
Minerva Chir. 1997 Nov;52(11):1293-7.
9
Vagotomy and drainage for elective treatment of peptic ulcers.选择性迷走神经切断术及引流术治疗消化性溃疡
Surg Gynecol Obstet. 1978 Mar;146(3):349-52.
10
[Changed ulcer surgery in the era of H2-blockers].[H2受体阻滞剂时代的溃疡手术变革]
Duodecim. 1991;107(6):435-40.

引用本文的文献

1
Analysis of risk factors for postoperative morbidity in perforated peptic ulcer.分析穿孔性消化性溃疡术后发病率的相关因素。
J Gastric Cancer. 2012 Mar;12(1):26-35. doi: 10.5230/jgc.2012.12.1.26. Epub 2012 Mar 30.
2
Operations for peptic ulcer disease: paradigm lost.消化性溃疡疾病的手术治疗:范式已失。
J Gastrointest Surg. 2001 Jul-Aug;5(4):438-43. doi: 10.1016/s1091-255x(01)80074-3.